UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A nomogram for predicting severe myelosuppression in small cell lung cancer patients following the first-line chemotherapy

Scientific reports, 2023-10, Vol.13 (1), p.17464-17464, Article 17464

2023

Volltextzugriff (PDF)

Naringenin alleviates bone cancer pain via NF-κB/uPA/PAR2 pathway in mice

Journal of orthopaedic surgery (Hong Kong), 2024-05, Vol.32 (2), p.10225536241266671

2024

Volltextzugriff (PDF)

The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain

Biomedicine & pharmacotherapy, 2021-09, Vol.141, p.111822-111822, Article 111822

2021

Volltextzugriff (PDF)

Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction

Biomedicine & pharmacotherapy, 2021-07, Vol.139, p.111653-111653, Article 111653

2021

Volltextzugriff (PDF)

Knockdown of PAR2 alleviates cancer-induced bone pain by inhibiting the activation of astrocytes and the ERK pathway

BMC musculoskeletal disorders, 2022-05, Vol.23 (1), p.514-514, Article 514

2022

Volltextzugriff (PDF)

Dysregulation of sphingolipid metabolism in pain

Frontiers in pharmacology, 2024, Vol.15, p.1337150-1337150

2024

Volltextzugriff (PDF)

Complementary and Alternative Medicine for Cancer Pain: An Overview of Systematic Reviews

Evidence-based complementary and alternative medicine, 2014-01, Vol.2014 (2014), p.1-9

2014

Volltextzugriff (PDF)

A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain

Supportive care in cancer, 2014-03, Vol.22 (3), p.825-836

2014

Volltextzugriff (PDF)

Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway

Oncology letters, 2016-08, Vol.12 (2), p.1380-1386

2016

Volltextzugriff (PDF)

PAR2-Mediated Upregulation of BDNF Contributes to Central Sensitization in Bone Cancer Pain

Molecular pain, 2014-05, Vol.10 (1), p.28-28

2014

Volltextzugriff (PDF)

Role of autophagy in the pathogenesis and regulation of pain

European journal of pharmacology, 2023-09, Vol.955, p.175859-175859, Article 175859

2023

Volltextzugriff (PDF)

Sonic Hedgehog Signaling Pathway: A Role in Pain Processing

Neurochemical research, 2023-06, Vol.48 (6), p.1611-1630

2023

Volltextzugriff (PDF)

Wnt Signaling Pathways: A Role in Pain Processing

Neuromolecular medicine, 2022-09, Vol.24 (3), p.233-249

2022

Volltextzugriff (PDF)

Protease-activated receptor 2 signalling pathways: a role in pain processing

Expert opinion on therapeutic targets, 2014-01, Vol.18 (1), p.15-27

2014

Volltextzugriff (PDF)

Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells

Oncology reports, 2017-08, Vol.38 (2), p.1224-1232

2017

Volltextzugriff (PDF)

Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis

Journal of cancer research and clinical oncology, 2020-11, Vol.146 (11), p.2913-2935

2020

Volltextzugriff (PDF)

The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence

Channels (Austin, Tex.), 2015-09, Vol.9 (5), p.235-243

2015

Volltextzugriff (PDF)

Engagement of signaling pathways of protease‐activated receptor 2 and μ‐opioid receptor in bone cancer pain and morphine tolerance

International journal of cancer, 2015-09, Vol.137 (6), p.1475-1483

2015

Volltextzugriff (PDF)

New insights of nociceptor sensitization in bone cancer pain

Expert opinion on therapeutic targets, 2015-02, Vol.19 (2), p.227-243

2015

Volltextzugriff (PDF)

Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance: PAR2 and Morphine Tolerance in Bone Cancer Pain

International journal of cancer, 2015-09, Vol.137 (6), p.1475-1483

2015

Volltextzugriff (PDF)

Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment

Evidence-based complementary and alternative medicine, 2015-01, Vol.2015 (2015), p.1-10

2015

Volltextzugriff (PDF)

Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model

Journal of translational medicine, 2015-11, Vol.13 (366), p.366-366, Article 366

2015

Volltextzugriff (PDF)

Increased Expression of Protease-Activated Receptor 2 and 4 Within Dorsal Root Ganglia in a Rat Model of Bone Cancer Pain

Journal of molecular neuroscience, 2015-03, Vol.55 (3), p.706-714

2015

Volltextzugriff (PDF)

Topical treatment with Xiaozheng Zhitong Paste alleviates bone cancer pain by inhibiting proteinase-activated receptor 2 signaling pathway

Oncology reports, 2015-09, Vol.34 (3), p.1449-1459

2015

Volltextzugriff (PDF)

Involvement of Protease-Activated Receptor 2 in Nociceptive Behavior in a Rat Model of Bone Cancer

Journal of molecular neuroscience, 2014-04, Vol.52 (4), p.566-576

2014

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(51)
Tagungsberichte
(1)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A nomogram for predicting severe myelosuppression in small cell lung cancer patients following the first-line chemotherapy

Naringenin alleviates bone cancer pain via NF-κB/uPA/PAR2 pathway in mice

The nonreceptor protein tyrosine kinase Src participates in every step of cancer-induced bone pain

Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction

Knockdown of PAR2 alleviates cancer-induced bone pain by inhibiting the activation of astrocytes and the ERK pathway

Dysregulation of sphingolipid metabolism in pain

Complementary and Alternative Medicine for Cancer Pain: An Overview of Systematic Reviews

A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain

Sinomenine inhibits A549 human lung cancer cell invasion by mediating the STAT3 signaling pathway

PAR2-Mediated Upregulation of BDNF Contributes to Central Sensitization in Bone Cancer Pain

Role of autophagy in the pathogenesis and regulation of pain

Sonic Hedgehog Signaling Pathway: A Role in Pain Processing

Wnt Signaling Pathways: A Role in Pain Processing

Protease-activated receptor 2 signalling pathways: a role in pain processing

Norcantharidin inhibits IL-6-induced epithelial-mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells

Efficacy and safety of TCM combined with chemotherapy for SCLC: a systematic review and meta-analysis

The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependence

Engagement of signaling pathways of protease‐activated receptor 2 and μ‐opioid receptor in bone cancer pain and morphine tolerance

New insights of nociceptor sensitization in bone cancer pain

Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine tolerance: PAR2 and Morphine Tolerance in Bone Cancer Pain

Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment

Anti-tumor enhancement of Fei-Liu-Ping ointment in combination with celecoxib via cyclooxygenase-2-mediated lung metastatic inflammatory microenvironment in Lewis lung carcinoma xenograft mouse model

Increased Expression of Protease-Activated Receptor 2 and 4 Within Dorsal Root Ganglia in a Rat Model of Bone Cancer Pain

Topical treatment with Xiaozheng Zhitong Paste alleviates bone cancer pain by inhibiting proteinase-activated receptor 2 signaling pathway

Involvement of Protease-Activated Receptor 2 in Nociceptive Behavior in a Rat Model of Bone Cancer

Suchergebnisse filtern